相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLC
Yang Yang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2023)
An adverse tumor-protective effect of IDO1 inhibition
Juliana C. N. Kenski et al.
CELL REPORTS MEDICINE (2023)
Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop
Chong Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Combination of IDO1(high) and CCL19(low) expression in the tumor tissue reduces survival in HPV positive cervical cancer
Jayakumar Hascitha et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses
Kunle Odunsi et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
Kwan Ho Tang et al.
CANCER DISCOVERY (2022)
Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
Rongjie Zhang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
Jiping Sun et al.
BIOENGINEERED (2022)
The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment
Xinting Huang et al.
CANCERS (2022)
Combination of apatinib with apo-IDO1 inhibitor for the treatment of colorectal cancer
Longbo Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
Roberta Liberato Pagni et al.
FRONTIERS IN IMMUNOLOGY (2022)
HOXC10 Promotes Metastasis in Colorectal Cancer by Recruiting Myeloid-derived Suppressor Cells
Jiao Yu et al.
JOURNAL OF CANCER (2022)
Tumor-Associated Microglia/Macrophages as a Predictor for Survival in Glioblastoma and Temozolomide-Induced Changes in CXCR2 Signaling with New Resistance Overcoming Strategy by Combination Therapy
Ruth M. Urbantat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
From Microbiome to Inflammation: The Key Drivers of Cervical Cancer
Zi-Wei Zhou et al.
FRONTIERS IN MICROBIOLOGY (2021)
Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
Yuan Cheng et al.
MOLECULAR CANCER (2021)
CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cells
Ji-Hea Kim et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma
Xiaobei Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway
Ya-Ling Qi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Tumor immune microenvironment in cancer patients with leukocytosis
Kyung Hwan Kim et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Alvaro Teijeira et al.
IMMUNITY (2020)
Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression
Naofumi Mukaida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802
Sanjeev Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Reciprocal Regulation Between Indoleamine 2,3-Dioxigenase 1 and Notch1 Involved in Radiation Response of Cervical Cancer Stem Cells
Hui-Ying Low et al.
CANCERS (2020)
Mechanisms of Cancer Resistance to Immunotherapy
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
Cervical cancer in low and middle-income countries
Rodney Hull et al.
ONCOLOGY LETTERS (2020)
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer
Danny Rischin et al.
GYNECOLOGIC ONCOLOGY (2020)
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Daniela Bruni et al.
NATURE REVIEWS CANCER (2020)
IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis
Kumar S. Bishnupuri et al.
CANCER RESEARCH (2019)
Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
Kyung Hae Jung et al.
CLINICAL CANCER RESEARCH (2019)
Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer
Paloma Almeida Venancio et al.
CANCER CYTOPATHOLOGY (2019)
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina Long et al.
LANCET ONCOLOGY (2019)
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
Erik Ladomersky et al.
CLINICAL CANCER RESEARCH (2018)
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Qian Huang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
Hatem Soliman et al.
Oncotarget (2018)
GRO-alpha and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NF kappa B signaling cascade
Mingo Ming-Ho Yung et al.
THERANOSTICS (2018)
CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells
Xiaona Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
Tara C. Mitchell et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Jean-Sebastien Frenel et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen
Megan E. Spurgeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer
Sreenivas Adurthi et al.
SCIENTIFIC REPORTS (2017)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Analysis of Kynurenine/Tryptophan ratio and expression of IDO1 and 2 mRNA in tumour tissue of cervical cancer patients
Jayakumar Hascitha et al.
CLINICAL BIOCHEMISTRY (2016)
Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer
Shi-liang Gui et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9
Ye Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
Bharat Devapatla et al.
PLOS ONE (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
Renaud Grepin et al.
CANCER RESEARCH (2014)
Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant Feature
Seiji Mabuchi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma
Ping Sui et al.
MEDICAL ONCOLOGY (2014)
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
Valentina Folgiero et al.
ONCOTARGET (2014)
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike M. Litzenburger et al.
ONCOTARGET (2014)
Correlation of MCM2 detection with stage and virology of cervical cancer
Sergio Menezes Amaro Filho et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Indoleamine 2,3-Dioxygenase Activity Contributes to Local Immune Suppression in the Skin Expressing Human Papillomavirus Oncoprotein E7
Deepak Mittal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue
Enoc M. Cortes-Malagon et al.
VIROLOGY (2013)
Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
L. Ferdinande et al.
BRITISH JOURNAL OF CANCER (2012)
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Y. S. Lee et al.
BRITISH JOURNAL OF CANCER (2012)
Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives
Jessica Godin-Ethier et al.
CLINICAL CANCER RESEARCH (2011)
Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice
Guelay Bulut et al.
PLOS ONE (2011)
Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer
Chandra M. Ohri et al.
BMC CANCER (2010)
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
CXCL8 and its cognate receptors in melanoma progression and metastasis
Seema Singh et al.
FUTURE ONCOLOGY (2010)
Indoleamine 2,3-Dioxygenase Tissue Distribution and Cellular Localization in Mice: Implications for Its Biological Functions
Xiangchen Dai et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase-Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Feng Qian et al.
CANCER RESEARCH (2009)
Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma
Hiroshi Urakawa et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer
Takafumi Nakamura et al.
CANCER SCIENCE (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model
T Brake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
